NO307705B1 - Substituted N-ethyl-glycine derivatives for the production of PNA and PNA/DNA hybrids, as well as the use of the same for the production of PNA and PNA/DNA hybrids - Google Patents

Substituted N-ethyl-glycine derivatives for the production of PNA and PNA/DNA hybrids, as well as the use of the same for the production of PNA and PNA/DNA hybrids

Info

Publication number
NO307705B1
NO307705B1 NO950959A NO950959A NO307705B1 NO 307705 B1 NO307705 B1 NO 307705B1 NO 950959 A NO950959 A NO 950959A NO 950959 A NO950959 A NO 950959A NO 307705 B1 NO307705 B1 NO 307705B1
Authority
NO
Norway
Prior art keywords
pna
production
dna hybrids
ethyl
substituted
Prior art date
Application number
NO950959A
Other languages
Norwegian (no)
Other versions
NO950959L (en
NO950959D0 (en
Inventor
Gerhard Breipohl
Eugen Uhlmann
Jochen Knolle
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO950959D0 publication Critical patent/NO950959D0/en
Publication of NO950959L publication Critical patent/NO950959L/en
Publication of NO307705B1 publication Critical patent/NO307705B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
NO950959A 1994-03-14 1995-03-13 Substituted N-ethyl-glycine derivatives for the production of PNA and PNA/DNA hybrids, as well as the use of the same for the production of PNA and PNA/DNA hybrids NO307705B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4408534A DE4408534A1 (en) 1994-03-14 1994-03-14 Substituted N-ethyl-glycine derivatives for the production of PNA and PNA / DNA hybrids

Publications (3)

Publication Number Publication Date
NO950959D0 NO950959D0 (en) 1995-03-13
NO950959L NO950959L (en) 1995-09-15
NO307705B1 true NO307705B1 (en) 2000-05-15

Family

ID=6512698

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950959A NO307705B1 (en) 1994-03-14 1995-03-13 Substituted N-ethyl-glycine derivatives for the production of PNA and PNA/DNA hybrids, as well as the use of the same for the production of PNA and PNA/DNA hybrids

Country Status (8)

Country Link
US (1) US6075143A (en)
EP (1) EP0672661A1 (en)
JP (1) JPH07258222A (en)
AU (1) AU686729B2 (en)
CA (1) CA2144474C (en)
DE (1) DE4408534A1 (en)
FI (1) FI120199B (en)
NO (1) NO307705B1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6133444A (en) * 1993-12-22 2000-10-17 Perseptive Biosystems, Inc. Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
US6919441B2 (en) 1994-03-14 2005-07-19 Aventis Pharma Deutschland Gmbh Polyamide-oligonucleotide derivatives, their preparation and use
DE69632324T2 (en) * 1995-06-07 2005-06-16 PerSeptive Biosystems, Inc., Framingham PNA-DNA CHIMESES AND PNA SYNTHESES FOR THEIR PREPARATION
DE19532553A1 (en) * 1995-09-04 1997-03-06 Hoechst Ag Process for the preparation of substituted N-ethyl-glycine derivatives
US6191165B1 (en) 1996-05-31 2001-02-20 Allelix Neuroscience Inc. Pharmaceutical for treatment of neurological and neuropsychiatric disorders
DE19640974A1 (en) * 1996-10-04 1998-04-16 Bayer Ag Building blocks for DNA / PNA cooligomers
CZ299816B6 (en) * 1997-05-14 2008-12-03 Morphochem Ag Isonitrile compounds for preparation of polymers containing nucleic bases as side groups
US9879012B2 (en) 2012-03-29 2018-01-30 Regents Of The University Of Colorado, A Body Corporate Click nucleic acids
CA2938875A1 (en) 2014-02-06 2015-08-13 The Regents Of The University Of Colorado, A Body Corporate Thiol-x click foldamers for polymer affinity and catalysis libraries
CN105541728B (en) * 2015-07-27 2018-07-24 宁夏联森生物科技有限公司 A kind of preparation method of N-4 benzoylcytosines
US10508116B2 (en) 2016-10-07 2019-12-17 The Regents Of The University Of Colorado, A Body Click nucleic acid polymers and methods of use

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2627988A1 (en) * 1976-06-23 1978-01-05 Max Planck Gesellschaft SECRETARY PROVISION
US4213968A (en) * 1978-06-05 1980-07-22 Coy David Howard Enkephalin derivatives
US4213893A (en) * 1978-10-12 1980-07-22 Miles Laboratories, Inc. Flavin adenine dinucleotide-labeled conjugates for use in specific binding assays
JPS55135595A (en) * 1979-04-03 1980-10-22 Toyo Soda Mfg Co Ltd Preparation of dipeptide
US5470974A (en) * 1985-03-15 1995-11-28 Neu-Gene Development Group Uncharged polynucleotide-binding polymers
CS263951B1 (en) * 1985-04-25 1989-05-12 Antonin Holy 9-(phosponylmethoxyalkyl)adenines and method of their preparation
US5227497A (en) * 1988-04-04 1993-07-13 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Process for preparing N2 -(1-carboxy-3-phenylpropyl)-L-lysine derivative
EP0350145A3 (en) * 1988-04-28 1990-07-04 Yamanouchi Pharmaceutical Co. Ltd. Pyridylthiazolidine carboxamide derivatives and their intermediates and production of both
DE4016596A1 (en) * 1990-05-23 1991-11-28 Hoechst Ag A NEW CLUTCH REAGENT FOR PEPTIDE SYNTHESIS
US5614498A (en) * 1990-06-07 1997-03-25 Banyu Pharmaceutical Co., Ltd. Endothelin antagonistic substance
US5539082A (en) * 1993-04-26 1996-07-23 Nielsen; Peter E. Peptide nucleic acids
DK51092D0 (en) * 1991-05-24 1992-04-15 Ole Buchardt OLIGONUCLEOTIDE ANALOGUE DESCRIBED BY PEN, MONOMERIC SYNTHONES AND PROCEDURES FOR PREPARING THEREOF, AND APPLICATIONS THEREOF
MX9207334A (en) * 1991-12-18 1993-08-01 Glaxo Inc NUCLEIC ACIDS PEPTIDICS AND PHARMACEUTICAL FORMULATION CONTAINING THEM
ATE194981T1 (en) * 1992-04-30 2000-08-15 Taiho Pharmaceutical Co Ltd OXAZOLIDINE DERIVATIVE AND ITS PHARMACEUTICALLY ACCEPTABLE SALT
DE4331012A1 (en) * 1993-09-13 1995-03-16 Bayer Ag Nucleic acid-binding oligomers with N-branching for therapy and diagnostics
JPH11503713A (en) * 1993-12-22 1999-03-30 パーセプティブ・バイオシステムズ・インコーポレーテッド Guanine synthon for peptide nucleic acid synthesis and method for preparing the same
MY119161A (en) * 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities

Also Published As

Publication number Publication date
JPH07258222A (en) 1995-10-09
DE4408534A1 (en) 1995-09-28
CA2144474A1 (en) 1995-09-15
FI951128A0 (en) 1995-03-10
NO950959L (en) 1995-09-15
AU1479995A (en) 1995-09-21
NO950959D0 (en) 1995-03-13
AU686729B2 (en) 1998-02-12
FI951128A (en) 1995-09-15
CA2144474C (en) 2010-11-30
US6075143A (en) 2000-06-13
FI120199B (en) 2009-07-31
EP0672661A1 (en) 1995-09-20

Similar Documents

Publication Publication Date Title
AU6230098A (en) Isoquinolinone derivatives, process for preparing the same, and their use as phosphodiesterase inhibitors
ATE294785T1 (en) 2-AMINOTHIAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS ANTI-TUMOR AGENTS
NO20015156D0 (en) 5-Pyridyl-1,3-Azole Compounds, Process for Production of the Same and Their Use
NO961006L (en) Phosphonomononucleic acids, processes for their preparation and use of the compounds
DE69933283D1 (en) PHOTOACTIVABLE NUCLEIC ACID DERIVATIVES
DE9417778U1 (en) Forstner drills
DE69726593D1 (en) BENZOHETEROCYCLIC DISTAMYCINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS ANTITUMOR AND ANTIVIRAL AGENTS
NO962643D0 (en) Pyridazinone derivatives as well as process for preparing the same
DE59409541D1 (en) BICYCLENE DERIVATIVES, THEIR PRODUCTION AND USE
NO307705B1 (en) Substituted N-ethyl-glycine derivatives for the production of PNA and PNA/DNA hybrids, as well as the use of the same for the production of PNA and PNA/DNA hybrids
TR28254A (en) Alpha-pyrimidinyl acrylic acid derivatives.
DE69524611D1 (en) Pyrimidone DERIVATIVES
DE69801795D1 (en) INDOLYL-PYRROLYLIDENMETHYLPYRROL DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
EE9600011A (en) Novel dialkoxy-pyridinyl-benzimidazole derivatives
NO307708B1 (en) ferrocene derivatives
DE3586324T2 (en) TETRAHYDROPHTHALIMIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE.
NO985535L (en) Process for the preparation of 1,3-alkanediols
FI941149A (en) 2,4-diamino-3-hydroxycarboxylic acid derivatives
ATE485271T1 (en) ANTHISTAMINIC PIPERIDED DERIVATIVES AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION THEREOF
DE59608892D1 (en) IMINOOXYPHENYL ACID ACID DERIVATIVES, METHODS AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION AND THEIR USE
NO306402B1 (en) 3-arylalkenyl-1,2,4-oxadiazole derivatives and their use, as well as intermediates for obtaining the derivatives
FI972624A0 (en) 19-norprogesterone derivatives containing 14alpha, 17alpha-C2 bridge
ATE182133T1 (en) NAPHTOQUINONE DERIVATIVES
DE69932578D1 (en) TRIFLUORO-METHYLTHIOMETHYL-BENZOLE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
TR27776A (en) 2-oxymino-2-thienyl-acetic acid derivatives.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees